MedPath

Effect of amla in honey in the correction of anemia in pregnancy

Phase 1
Conditions
Health Condition 1: D508- Other iron deficiency anemias
Registration Number
CTRI/2024/04/066244
Lead Sponsor
JIPMER
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Hemoglobin level between 9 to 11 milligram per deciliter

Age between 18 to 35 years

1st and 2nd trimester of pregnancy

On oral iron therapy

Exclusion Criteria

Patients with a history of anemia due to any other conditions like bleeding piles cardiac or renal or liver disorders

Diabetes Mellitus

Hypertension

Pregnancy induced complications like hyperemesis gravidarum antepartum hemorrhage pre eclampsia eclampsia GDM jaundice

Patients with a history of drug abuse

Patients with a history of allergy to amla or honey

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hemoglobin level <br/ ><br>Hematological profile <br/ ><br>Indices of iron homeostasisTimepoint: 45 days
Secondary Outcome Measures
NameTimeMethod
Quality of lifeTimepoint: 45 days
© Copyright 2025. All Rights Reserved by MedPath